Skip to content

Safety Study of Outdoor and Indoor Mobility in People With Spinal Cord Injury (ROBOtics Spinal Cord Injury EKSO).

ROBOticsSpinalCordInjuryEKSO: Outdoor and Indoor Mobility in People With SCI.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02065830
Acronym
ROBOSCIEKSO
Enrollment
30
Registered
2014-02-19
Start date
2014-03-31
Completion date
2016-03-31
Last updated
2022-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Keywords

Robot, Spinal Cord Injury, Gait, Quality of life, Rehabilitation, Lower Limb

Brief summary

The aim of this study will be to evaluate the safety and the efficacy of a new robotic exoskeleton device in subjects with Spinal Cord Injury (SCI) and in subjects with other neurological disease with an impairment of lower limbs.

Detailed description

In this study, 30 participants with chronic spinal cord injury will undergo a 8-week training schedule for ambulation with the EKSO™ device. Ekso™ is a wearable bionic suit which enables individuals with any amount of lower extremity weakness to stand up and walk over ground with a natural, full weight bearing, reciprocal gait. Walking is achieved by the user's weight shifts to activate sensors in the device which initiate steps. Battery-powered motors drive the legs, replacing deficient neuromuscular function. Ekso provides functional based rehabilitation, over ground gait training, and upright, weight bearing exercise unlike any other. It has been designed for the needs of busy therapists treating a wide range of patients in a single day. The suit is strapped over the users´ clothing with easy adjustments to transition between patients in as little as five minutes. Before, during and after training sessions the subjects will perform standardised assessments and complete questionnaires to assess the functional and psychological effects of the exoskeleton.

Interventions

DEVICEEKSO

The subjects will undergo inpatient rehabilitation consisting of a treatment cycle of 30/40 training section using the robot EKSO system device, according to individually tailored exercise scheduling. The practice will include robot-assisted walking at variable speeds for 45/60 min and balance training.

Sponsors

IRCCS San Raffaele Roma
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Chronic motor complete or incomplete cervical and thoracic (C7-T12) spinal cord injury. * Skin integrity. * Adequate hip, knee and ankle range of motion. * Spasticity level of 3 or less (Ashworth scale).

Exclusion criteria

* Cardiological or respiratory comorbidity. * Hemodynamic instability. * Presence of unhealed fractures. * Presence of heterotopic ossification that may impede walking. * Presence of osteoporosis.

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Gait Spatiotemporal and Kinematic parameters at 6 months.Ekso training at 0 and 8 weeks, and 24-week follow-up.Change in score between 0 and 24 weeks. 3D Gait Analysis will be collected at baseline (inclusion) (T0) after 30/40 robot session an expected average of 8 weeks (T1) and at the follow-up examination after 6 months from the training conclusion (T2).

Secondary

MeasureTime frameDescription
Participant Satisfaction Questionnaire.Ekso training at 0 and 8 weeks, and 24-week follow-upChange in score between 0 and 24 weeks. The 10 questions will be asked for each subject during and upon the completion of the active participation phase of the treatment.
Change in blood pressure and heart rate during the training.Ekso training at 0 and 8 weeks, and 24-week follow-up.Blood pressure and heart rate will be monitorized every day during the training and the data will be collected at baseline (inclusion) (T0) after 30/40 robot session an expected average of 8 weeks (T1) and at the follow-up examination after 6 months from the training conclusion (T2).
6 minutes walking test.Ekso training at 0 and 8 weeks, and 24-week follow-up.Change in score between 0 and 24 weeks. The 6 minutes walking test will be collected in indoor and outdoor condition at baseline (inclusion) (T0) after 30/40 robot session an expected average of 8 weeks (T1) and at the follow-up examination after 6 months from the training conclusion (T2).
Timed Up and Go test.Ekso training at 0 and 8 weeks, and 24-week follow-up.Change in score between 0 and 24 weeks. Timed Up and Go test will be collected in indoor and outdoor condition at baseline (inclusion) (T0) after 30/40 robot session an expected average of 8 weeks (T1) and at the follow-up examination after 6 months from the training conclusion (T2).

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026